Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group.

Coelingh Bennink, H J; Fauser, B C; Out, H J

Coelingh Bennink, H J; Fauser, B C; Out, H J.

Affiliation

Coelingh Bennink HJ; NV Organon, Oss, The Netherlands.

Fertil Steril ; 69(1): 19-25, 1998 Jan.

Article in En | MEDLINE | ID: mdl-9457926

Subject(s)

Anovulation/drug therapy; Clomiphene/therapeutic use; Fertility Agents, Female/therapeutic use; Follicle Stimulating Hormone/therapeutic use; Gonadotropins/blood; Menotropins/therapeutic use; Adult; Anovulation/physiopathology; Chronic Disease; Drug Resistance; Female; Follicle Stimulating Hormone/urine; Humans; Ovulation; Prospective Studies; Recombinant Proteins; Reference Values; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Clomiphene / Fertility Agents, Female / Follicle Stimulating Hormone / Gonadotropins / Anovulation / Menotropins Type of study: Clinical_trials / Observational_studies Limits: Adult / Female / Humans Language: En Journal: Fertil Steril Year: 1998 Document type: Article Affiliation country: Netherlands Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links